Rewind Therapeutics

About:

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.

Website: https://rwdtx.com

Twitter/X: rewind_tx

Top Investors: Boehringer Ingelheim Venture Fund, PMV, M Ventures, Agentschap Innoveren & Ondernemen, Sunstone Life Science Ventures

Description:

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medical practitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.

Total Funding Amount:

18.1M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Antwerp, Antwerpen, Belgium

Founded Date:

2017-01-01

Contact Email:

information(AT)rewindtherapeutics.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2023-01-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai